Antimalarial activity of KAF156 in falciparum and vivax malaria
<strong>Background:</strong> KAF156 belongs to a new class of antimalarials (imidazolopiperazines), with activity against asexual and sexual blood stages and the pre-erythrocytic liver stages of malaria parasites. <strong>Methods:</strong> We conducted a phase 2, open-label,...
Main Authors: | Nosten, F, White, N, Phyo, A, Thanh, D, Uthaisin, C, Hanboonkunupakarn, B, Pukrittayakamee, S, Jittamala, P, Chuthasmit, K, Cheung, M, Feng, Y, Li, R, Magnusson, B, Sultan, M, Wieser, D, Xun, X, Zhao, R, Diagana, T, Pertel, P, Leong, F |
---|---|
Format: | Journal article |
Published: |
Massachusetts Medical Society
2016
|
Similar Items
-
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.
by: Kuhen, K, et al.
Published: (2014) -
Spiroindolone KAE609 for falciparum and vivax malaria.
by: White, N, et al.
Published: (2014) -
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
by: Phyo, A, et al.
Published: (2016) -
Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (2004) -
Antimalarial effects of rifampin in Plasmodium vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (1994)